top of page

Nexus UCD, Dublin 4. D04V2N9

AI Cancer Trial Finder for Charities
AI Cancer Trial Finding for Charities

The “finder” can be easily added to a website and is free to use for both charities and their communities.

Akkure Partners with Microsft AI
Akkure Partners with Microsoft AI

Akkure deploys Clinical Trials solution via partnership with Microsoft AI for Precision Medicine.

Free Cancer Trial Finder
Free AI Cancer Trial Finder for your site

The “finder” can be easily added to a website and is free to use for both charities and their communities.

Irish medtech start-up Akkure beats crowdfunding target.

Irish medtech start-up Akkure beats crowdfunding target.

Charlie Taylor, The Irish Times

31 January 2021 at 22:00:00

Source: Charlie Taylor, The Irish Times, Feb 1st 2021

Digital health start-up Akkure Genomics has easily surpassed its €500,000 crowdfunding campaign target, just days after launching the initiative.

The company has secured €615,000 in funding since Friday with the campaign to run till the end of February.

Akkure was initially looking to raise €500,000 at a pre-money valuation of €4 million.

The company, which is targeting the €60 billion global clinical trials market, was founded in 2019 by Prof Oran Rigby, a consultant in intensive care medicine and surgery, and Dr Amy Hollingworth, a respiratory and lung transplant specialist.

Former senator Prof John Crown, a senior consultant medical oncologist and cancer trials expert at St Vincent’s University Hospital, was announced chair of the company’s medical research board last week.

Akkure is developing improved technology to allow patients partake in precision medical trials. Simultaneously, the company is deploying its patented robotic telemedicine automated clinical consultation technology to facilitate virtual and remote trial participation allowing global access for patients.

The NovaUCD-headquartered start-up has to date secured €1.6 million in funding through the Disruptive Technology Innovation Fund (DTIF), high-net worth medical investors and Enterprise Ireland. That funding, which is for a project involving other partners, is aimed at project developing a blockchain and AI-enabled stratified trial system to better recruit and reward patients for international clinical trials and data sharing. Akkure has sole commercialisation rights for the project.

Akkure’s crowdfunding campaign is being held via Spark, an Irish-founded platform that has completed 15 fundraising campaigns to date.

bottom of page